- Home
- CCLD vs MIST Comparison
CCLD vs MIST Comparison
Compare CCLD & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCLD
- MIST
- Stock Information
- Founded
- CCLD 1999
- MIST 2003
- Country
- CCLD United States
- MIST Canada
- Employees
- CCLD N/A
- MIST N/A
- Industry
- CCLD Computer Software: Prepackaged Software
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- CCLD Technology
- MIST Health Care
- Exchange
- CCLD Nasdaq
- MIST Nasdaq
- Market Cap
- CCLD 105.8M
- MIST 132.5M
- IPO Year
- CCLD 2014
- MIST N/A
- Fundamental
- Price
- CCLD $2.37
- MIST $1.46
- Analyst Decision
- CCLD Buy
- MIST Strong Buy
- Analyst Count
- CCLD 2
- MIST 2
- Target Price
- CCLD $3.00
- MIST $7.50
- AVG Volume (30 Days)
- CCLD 174.9K
- MIST 2.8M
- Earning Date
- CCLD 08-05-2025
- MIST 08-07-2025
- Dividend Yield
- CCLD N/A
- MIST N/A
- EPS Growth
- CCLD N/A
- MIST N/A
- EPS
- CCLD N/A
- MIST N/A
- Revenue
- CCLD $112,507,000.00
- MIST N/A
- Revenue This Year
- CCLD $2.74
- MIST N/A
- Revenue Next Year
- CCLD $7.52
- MIST N/A
- P/E Ratio
- CCLD N/A
- MIST N/A
- Revenue Growth
- CCLD N/A
- MIST N/A
- 52 Week Low
- CCLD $1.14
- MIST $0.63
- 52 Week High
- CCLD $4.84
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- CCLD 50.28
- MIST 41.55
- Support Level
- CCLD $2.33
- MIST $1.48
- Resistance Level
- CCLD $2.49
- MIST $1.64
- Average True Range (ATR)
- CCLD 0.10
- MIST 0.16
- MACD
- CCLD -0.01
- MIST -0.04
- Stochastic Oscillator
- CCLD 43.48
- MIST 8.33
About CCLD CareCloud Inc.
CareCloud Inc is a healthcare information technology company. The company provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).